跳至主要内容
临床试验/EUCTR2007-006686-32-ES
EUCTR2007-006686-32-ES进行中(未招募)不适用

Identificación de biomarcadores proteicos asociados a resistencia a la aspirina y a tienopiridinas en pacientes con cardiopatía isquémica establecida. (ESTUDIO BIRAT).Identification of new protein biomarkers associated with aspirin and thienopyridine resistance in stable coronary ischaemic patients: a proteomic study. (BIRAT Study). - BIRAT

FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS0 个研究点开始时间: 2008年3月27日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Men and women, ages 18 or older
  • -Documented history of coronary disease define as >50% stenosis in >/= 1 major coronary artery, clinically stable for at least 6 months.
  • -Stable clinical situation at least during the last month.
  • -Patients receiving AAS 100 mg daily at least during the last month and with the last AAS dosage 24 hours before
  • -Written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Another antithrombotic treatment than AAS in the previous month
  • -Presence of active infectious or tumoral disease
  • -Recent trauma or major surgery, angioplasty or cathetherism during the last month
  • -Atorvastatin treated patients
  • -Patients receiving antiinflammatory treatment during the last month
  • -No written consent

研究者

发起方
FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS

相似试验

已完成
不适用
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)
JPRN-UMIN000038467niversity of the Ryukyus85
招募中
不适用
Identification of Protein markers in ovarian cancerCancer - Ovarian and primary peritonealOvarian Cancer
ACTRN12608000519358Ovarian cancer research fund100
进行中(未招募)
不适用
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.
EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular
尚未招募
不适用
Application of proteomics to aid biomarker discovery in smear positive patients of P.vivax and P.falciparum malaria
CTRI/2010/091/000451Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076100
招募中
不适用
Identification of Blood Biomarkers Associated with Cardiac Remodeling after Myocardial InfarctioMyocardial Infarction
JPRN-UMIN000045598Graduate School of Medicine and Faculty of Medicine, The University of Tokyo200